vs
Side-by-side financial comparison of QVC INC (QVCD) and Zoetis (ZTS). Click either name above to swap in a different company.
QVC INC is the larger business by last-quarter revenue ($2.4B vs $2.3B, roughly 1.1× Zoetis). Zoetis runs the higher net margin — 26.6% vs 1.5%, a 25.0% gap on every dollar of revenue. On growth, Zoetis posted the faster year-over-year revenue change (2.9% vs -8.9%). Over the past eight quarters, QVC INC's revenue compounded faster (7.1% CAGR vs -2.1%).
QVC Group, is an American media conglomerate controlled by company chairman John C. Malone, who owns a majority of the voting shares.
Zoetis Inc. (/zō-EH-tis/) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total re...
QVCD vs ZTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $2.4B | $2.3B |
| Net Profit | $37.0M | $601.0M |
| Gross Margin | 32.5% | 71.7% |
| Operating Margin | 5.6% | — |
| Net Margin | 1.5% | 26.6% |
| Revenue YoY | -8.9% | 2.9% |
| Net Profit YoY | 103.0% | -0.2% |
| EPS (diluted) | — | $1.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $2.3B | ||
| Q4 25 | $2.4B | $2.4B | ||
| Q3 25 | $2.0B | $2.4B | ||
| Q2 25 | $2.0B | $2.5B | ||
| Q1 25 | $1.9B | $2.2B | ||
| Q4 24 | $2.7B | $2.3B | ||
| Q3 24 | $2.1B | $2.4B | ||
| Q2 24 | $2.1B | $2.4B |
| Q1 26 | — | $601.0M | ||
| Q4 25 | $37.0M | $603.0M | ||
| Q3 25 | $2.0M | $721.0M | ||
| Q2 25 | $-2.2B | $718.0M | ||
| Q1 25 | $-42.0M | $631.0M | ||
| Q4 24 | $-1.2B | $581.0M | ||
| Q3 24 | $51.0M | $682.0M | ||
| Q2 24 | $53.0M | $624.0M |
| Q1 26 | — | 71.7% | ||
| Q4 25 | 32.5% | 70.2% | ||
| Q3 25 | 33.6% | 71.5% | ||
| Q2 25 | 35.4% | 73.6% | ||
| Q1 25 | 33.3% | 72.0% | ||
| Q4 24 | 32.6% | 69.5% | ||
| Q3 24 | 34.7% | 70.6% | ||
| Q2 24 | 35.6% | 71.7% |
| Q1 26 | — | — | ||
| Q4 25 | 5.6% | 31.9% | ||
| Q3 25 | 4.6% | 37.0% | ||
| Q2 25 | -114.5% | 36.7% | ||
| Q1 25 | 1.5% | 36.5% | ||
| Q4 24 | -47.1% | 31.6% | ||
| Q3 24 | 7.8% | 36.6% | ||
| Q2 24 | 7.6% | 33.0% |
| Q1 26 | — | 26.6% | ||
| Q4 25 | 1.5% | 25.3% | ||
| Q3 25 | 0.1% | 30.0% | ||
| Q2 25 | -109.1% | 29.2% | ||
| Q1 25 | -2.2% | 28.4% | ||
| Q4 24 | -46.0% | 25.1% | ||
| Q3 24 | 2.4% | 28.6% | ||
| Q2 24 | 2.5% | 26.4% |
| Q1 26 | — | $1.42 | ||
| Q4 25 | — | $1.37 | ||
| Q3 25 | — | $1.63 | ||
| Q2 25 | — | $1.61 | ||
| Q1 25 | — | $1.41 | ||
| Q4 24 | — | $1.29 | ||
| Q3 24 | — | $1.50 | ||
| Q2 24 | — | $1.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.5B | — |
| Total DebtLower is stronger | $1.0M | — |
| Stockholders' EquityBook value | $1.2B | — |
| Total Assets | $8.5B | — |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $1.5B | — | ||
| Q3 25 | — | $2.1B | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | — | $1.7B | ||
| Q4 24 | $297.0M | $2.0B | ||
| Q3 24 | $297.0M | $1.7B | ||
| Q2 24 | $315.0M | $1.6B |
| Q1 26 | — | — | ||
| Q4 25 | $1.0M | — | ||
| Q3 25 | $5.0B | — | ||
| Q2 25 | $4.0B | — | ||
| Q1 25 | $4.0B | — | ||
| Q4 24 | $3.3B | — | ||
| Q3 24 | $3.4B | — | ||
| Q2 24 | $3.7B | — |
| Q1 26 | — | — | ||
| Q4 25 | $1.2B | $3.3B | ||
| Q3 25 | $1.2B | $5.4B | ||
| Q2 25 | $1.2B | $5.0B | ||
| Q1 25 | $3.3B | $4.7B | ||
| Q4 24 | $3.3B | $4.8B | ||
| Q3 24 | $4.6B | $5.2B | ||
| Q2 24 | $4.3B | $5.0B |
| Q1 26 | — | — | ||
| Q4 25 | $8.5B | $15.5B | ||
| Q3 25 | $8.3B | $15.2B | ||
| Q2 25 | $7.4B | $14.5B | ||
| Q1 25 | $9.7B | $14.1B | ||
| Q4 24 | $9.9B | $14.2B | ||
| Q3 24 | $9.9B | $14.4B | ||
| Q2 24 | $11.2B | $14.2B |
| Q1 26 | — | — | ||
| Q4 25 | 0.00× | — | ||
| Q3 25 | 4.30× | — | ||
| Q2 25 | 3.42× | — | ||
| Q1 25 | 1.22× | — | ||
| Q4 24 | 1.01× | — | ||
| Q3 24 | 0.73× | — | ||
| Q2 24 | 0.87× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $245.0M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 6.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $245.0M | $893.0M | ||
| Q3 25 | $76.0M | $938.0M | ||
| Q2 25 | $52.0M | $486.0M | ||
| Q1 25 | $46.0M | $587.0M | ||
| Q4 24 | $189.0M | $905.0M | ||
| Q3 24 | $98.0M | $951.0M | ||
| Q2 24 | $164.0M | $502.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | $732.0M | ||
| Q3 25 | — | $805.0M | ||
| Q2 25 | — | $308.0M | ||
| Q1 25 | — | $438.0M | ||
| Q4 24 | — | $689.0M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | — | $370.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 30.7% | ||
| Q3 25 | — | 33.5% | ||
| Q2 25 | — | 12.5% | ||
| Q1 25 | — | 19.7% | ||
| Q4 24 | — | 29.7% | ||
| Q3 24 | — | 32.8% | ||
| Q2 24 | — | 15.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 6.7% | ||
| Q3 25 | — | 5.5% | ||
| Q2 25 | — | 7.2% | ||
| Q1 25 | — | 6.7% | ||
| Q4 24 | — | 9.3% | ||
| Q3 24 | — | 7.0% | ||
| Q2 24 | — | 5.6% |
| Q1 26 | — | — | ||
| Q4 25 | 6.62× | 1.48× | ||
| Q3 25 | 38.00× | 1.30× | ||
| Q2 25 | — | 0.68× | ||
| Q1 25 | — | 0.93× | ||
| Q4 24 | — | 1.56× | ||
| Q3 24 | 1.92× | 1.39× | ||
| Q2 24 | 3.09× | 0.80× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
QVCD
| Home | $754.0M | 31% |
| QVC International | $661.0M | 27% |
| Beauty | $260.0M | 11% |
| Apparel | $254.0M | 10% |
| Electronics | $187.0M | 8% |
| Accessories | $181.0M | 7% |
| Jewelry | $87.0M | 4% |
| Otherrevenue | $38.0M | 2% |
ZTS
| Companion Animal | $1.5B | 67% |
| Livestock | $720.0M | 32% |
| Contract Manufacturing & Human Health | $23.0M | 1% |
